Cytarabine
Pyrimidine Analogues
Sold as CYTOSAR
- Drug class
- Pyrimidine Analogues
- Availability
- See label
- Routes
- Intrathecal, Intravenous
- Markets covered
- 2
- Products on record
- 10
Overview
Cytarabine is an active pharmaceutical ingredient in the Pyrimidine Analogues group (L01BC). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 5 | May 15, 2026 |
| CA Canada | Health Canada | 5 | March 22, 2025 |
GBUnited Kingdom· MHRA
5 products
Uses
Cytarabine may be used alone or in combination with other antineoplastic agents. It is indicated alone or in combination for induction of remission and/or maintenance in patients with acute myeloid leukaemia, acute non- lymphoblastic leukaemias, acute lymphoblastic leukaemias, acute lymphocytic leukaemia, erythroleukaemia, blast crises of chronic myeloid leukaemia, diffuse histiocytic lymphomas (non-hodgkin's lymphomas of high malignancy), meningeal leukaemia and meningeal neoplasms.
Clinicians should refer to the current literature on combination therapy before initiating treatment.
How to take
CACanada· Health Canada
5 products
Uses
AND CLINICAL USE ............................................................................. 3 CONTRAINDICATIONS .................................................................................................. 4 WARNINGS AND PRECAUTIONS .................................................................................
4 ADVERSE REACTIONS................................................................................................. 10 DRUG INTERACTIONS .................................................................................................
15 DOSAGE AND ADMINISTRATION ............................................................................. 15 OVERDOSAGE ...............................................................................................................
26 ACTION AND CLINICAL PHARMACOLOGY ........................................................... 27 STORAGE AND STABILITY ......................................................................................... 29 SPECIAL HANDLING INSTRUCTIONS ......................................................................
Drug interactions
Known interactions involving Cytarabine. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 324. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL045150040 · revised April 10, 2026
- [2]Health Canada (DPD) · 02403811 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.